CytRx Corporation (NASDAQ:CYTR) on Mar. 5 reported financial results for the 12 months ended December 31, 2013, and also provided an overview of recent accomplishments and upcoming milestones for its clinical development programs. CytRx Corporation (NASDAQ:CYTR) stock performance was -6.17% in last session and finished the day at $5.32. Traded volume was 3,186,360 million shares in the last session and the average volume of the … Continue reading NASDAQ Bearish Stocks: CytRx Corporation (NASDAQ:CYTR), Alaska Communications Systems (NASDAQ:ALSK), VimpelCom (NASDAQ:VIP), Ambarella Inc (NASDAQ:AMBA)